389 related articles for article (PubMed ID: 26255991)
1. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
[TBL] [Abstract][Full Text] [Related]
2. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
3. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
[TBL] [Abstract][Full Text] [Related]
4. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
[TBL] [Abstract][Full Text] [Related]
5. Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome.
Scott D; Joham A; Teede H; Gibson-Helm M; Harrison C; Cassar S; Hutchison S; Ebeling PR; Stepto N; de Courten B
Nutrients; 2016 Nov; 8(12):. PubMed ID: 27916865
[TBL] [Abstract][Full Text] [Related]
6. Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training.
Joham AE; Teede HJ; Hutchison SK; Stepto NK; Harrison CL; Strauss BJ; Paul E; Watt MJ
Obesity (Silver Spring); 2012 Dec; 20(12):2390-6. PubMed ID: 22641183
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
8. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
Hutchison SK; Stepto NK; Harrison CL; Moran LJ; Strauss BJ; Teede HJ
J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
10. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
[TBL] [Abstract][Full Text] [Related]
11. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
13. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
14. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140
[TBL] [Abstract][Full Text] [Related]
15. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
17. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
18. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
Harrison CL; Stepto NK; Hutchison SK; Teede HJ
Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
[TBL] [Abstract][Full Text] [Related]
19. Serum Vitamin D Binding Protein Level Associated with Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome.
Kuliczkowska-Plaksej J; Pasquali R; Milewicz A; Lwow F; Jedrzejuk D; Bolanowski M
Horm Metab Res; 2019 Jan; 51(1):54-61. PubMed ID: 30408832
[TBL] [Abstract][Full Text] [Related]
20. Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short-term despite declining hyperandrogenaemia: Results of a longitudinal study with community controls.
Huddleston HG; Quinn MM; Kao CN; Lenhart N; Rosen MP; Cedars MI
Clin Endocrinol (Oxf); 2017 Dec; 87(6):775-782. PubMed ID: 29044581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
